Lee C Y, Bazer F W, Etherton T D, Simmen F A
Department of Dairy Science, University of Florida, Gainesville 32611.
Endocrinology. 1991 May;128(5):2336-44. doi: 10.1210/endo-128-5-2336.
The insulin-like growth factors (IGF-I and IGF-II) circulate in plasma in association with IGF-binding proteins (IGFBPs). As a first step to understanding the regulation of expression of these proteins in pigs, we characterized the ontogeny of circulating IGFs and IGFBPs during fetal and early postnatal development. Serum IGFs were separated from IGFBPs, before IGF RIA, by acidification and chromatography on C18 Sep-Pak cartridges. The IGF-I levels increased during the latter half of fetal life from 11 +/- 1 ng/ml on day 60 to 37 +/- 3 ng/ml on day 112 (2-3 days before term) and further increased postnatally to 227 +/- 21 to 265 +/- 26 ng/ml) and also increased higher than IGF-I levels, with no obvious developmental pattern, during fetal life (170 +/- 21 to 265 +/- 26 ng/ml) and also increased postnatally by 2-fold (463 +/- 29 ng/ml on day 42). These results support the view that IGF-II is a fetal and postnatal growth factor, whereas IGF-I is primarily a postnatal growth mediator in pigs. Serum IGF-binding proteins were identified by Western ligand blotting. Five IGFBPs with apparent mol wt of 43K, 39K, 34K, 31K, and 26K were detected in fetal and postnatal sera. The two largest proteins were shown to be glycoproteins and immunologically related to porcine (p) IGFBP-3, suggesting that they are glycosylation variants of pIGFBP-3. The abundance of these two IGFBPs increased coincidently with increasing serum IGF-I levels. The 34K IGFBP was immunologically related to rIGFBP-2 and was 2- to 3-fold more abundant in fetal serum than in postnatal serum. The 31K IGFBP was resolved into a triplet and also was a component of pIGFBP-3 immunoprecipitates. Similarly, the 26K IGFBP was present in pIGFBP-3 immunoprecipitates. The 31K and 26K IGFBPs represented a minor portion of serum IGF-binding activity in fetal and postnatal pigs and exhibited no obvious developmental patterns. It is hypothesized that the postnatal increases in serum IGF-I and 43K and 39K IGFBPs as well as the decrease in the 34K IGFBP are driven by GH action.
胰岛素样生长因子(IGF-I和IGF-II)在血浆中与IGF结合蛋白(IGFBPs)结合循环。作为了解猪体内这些蛋白质表达调控的第一步,我们对胎儿期和出生后早期发育过程中循环IGFs和IGFBPs的个体发生进行了表征。在进行IGF放射免疫分析之前,通过酸化和在C18 Sep-Pak柱上进行色谱分离,将血清IGFs与IGFBPs分开。IGF-I水平在胎儿期后半段从第60天的11±1 ng/ml增加到第112天(足月前2 - 3天)的37±3 ng/ml,并在出生后进一步增加到227±21至265±26 ng/ml;IGF-II水平在胎儿期(170±21至265±26 ng/ml)高于IGF-I水平,且无明显发育模式,出生后也增加了2倍(第42天为463±29 ng/ml)。这些结果支持以下观点:在猪中,IGF-II是胎儿期和出生后的生长因子,而IGF-I主要是出生后的生长调节因子。通过Western配体印迹法鉴定血清IGF结合蛋白。在胎儿和出生后血清中检测到5种表观分子量分别为43K、39K、34K、31K和26K的IGFBPs。两种最大的蛋白被证明是糖蛋白,且与猪(p)IGFBP-3免疫相关,表明它们是pIGFBP-3的糖基化变体。这两种IGFBPs的丰度与血清IGF-I水平的升高同时增加。34K IGFBP与rIGFBP-2免疫相关,在胎儿血清中的丰度比出生后血清高2至3倍。31K IGFBP可解析为一个三联体,也是pIGFBP-3免疫沉淀物的一个组分。同样,26K IGFBP也存在于pIGFBP-3免疫沉淀物中。31K和26K IGFBPs在胎儿和出生后猪的血清IGF结合活性中占一小部分,且无明显发育模式。据推测,出生后血清IGF-I、43K和39K IGFBPs的增加以及34K IGFBP的减少是由生长激素(GH)作用驱动的。